Cargando…
p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome
Autores principales: | Man, Na, Nimer, Stephen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003552/ https://www.ncbi.nlm.nih.gov/pubmed/29928471 http://dx.doi.org/10.18632/oncotarget.23402 |
Ejemplares similares
-
Attenuated Acceleration to Leukemia after Ezh2 Loss in Nup98-HoxD13 (NHD13) Myelodysplastic Syndrome
por: Ling, Victoria Y., et al.
Publicado: (2019) -
Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice
por: Kundu, Subhadip, et al.
Publicado: (2019) -
Depletion of Cytotoxic T-Cells Does Not Protect NUP98-HOXD13 Mice from Myelodysplastic Syndrome but Reveals a Modest Tumor Immunosurveillance Effect
por: Gough, Sheryl M., et al.
Publicado: (2012) -
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
por: Man, Na, et al.
Publicado: (2021) -
Progressive Genomic Instability in the Nup98-HoxD13 Model of MDS Correlates with Loss of the PIG-A Gene Product()()
por: Byrne, Michael, et al.
Publicado: (2014)